Table 1.
Demographic and clinical characteristics in hospitalized patients with severe Covid-19. Abbreviations: W, women; M, men; BMI, body mass index; T2D, type 2 diabetes; IMV, invasive mechanical ventilation. Normality of data distribution was estimated by the Shapiro–Wilk test. The unpaired Student’s T-test was used to compare numerical variables and data are presented as mean ± standard deviation. The chi-squared test was used to compare categorical variables and data are expressed as absolute values or percentages. * Differences were considered significant when p < 0.05.
| Parameters | Survivors (n = 34) |
Non-Survivors (n = 20) |
p Value |
|---|---|---|---|
| Gender (W/M) | 21/13 | 5/15 | 0.002 * |
| Age (years) | 54.06 ± 12.43 | 62.9 ± 14.18 | 0.020 * |
| BMI (kg/m2) | 28.24 ± 4.60 | 27.88 ± 4.05 | 0.903 |
| Obesity prevalence (%) | 52.17 | 41.66 | 0.277 |
| T2D prevalence (%) | 43.47 | 75.00 | 0.037 * |
| Hypertension prevalence (%) | 17.39 | 58.33 | 0.006 * |
| Coronary heart disease (%) | 8.69 | 33.33 | 0.033 * |
| IMV (%) | 30.43 | 83.33 | 0.001 * |
| Time to extubation (days) | 2.43 ± 0.79 | 3.66 ± 0.82 | 0.167 |
| Inpatient days (days) | 15.65 ± 3.13 | 8.41 ± 1.66 | 0.060 |
| Drug regimen | Aziythromycin, ceftriaxone, enoxaparin sodium, dexamethasone, and acetaminophen | - | |